The present invention relates to a nutritional composition such as an infant formula comprising phospholipids in an amount of at least 300 mg/L. Bioactive compounds may preferably be added to the nutritional composition. The present invention also relates to use of said nutritional composition by feeding an infant with the nutritional composition for reducing the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.
